Eupraxia Pharmaceuticals Inc. has announced participation in several upcoming investor and scientific conferences to present their clinical research. At the Osteoarthritis Research Society ...
TORONTO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery company ...
The Center for Clinical and Translational Science (CCTS) strives to build synergistic collaborations across the CTSA consortium, elevating translational science to a new heights. From March 5-7th, ...
Title: Expansion of an HSV-1-based gene therapy platform to treat Hailey-Hailey and Darier diseases Presenter: Bruce Nmezi, PhD Date and Time: May 9, 2025 from 4:30PM to 6:00PM PT Poster Session or ...
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback